Home > Insider Trading > Filing (0001562180-20-007062)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780883	Jr. Patrick James Nelli	C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-01	20,000	$10.80	120,848	No	4	M	Direct
Common Stock	Disposition	2020-12-01	33,382	$34.96	87,466	No	4	S	Direct
Common Stock	Disposition	2020-12-01	200	$35.85	87,266	No	4	S	Direct
Common Stock	Disposition	2020-12-02	8,261	$35.01	79,005	No	4	S	Direct
Common Stock	Disposition	2020-12-02	3,157	$35.96	75,848	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-12-01	20,000	$0.00	20,000	$10.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
115,460		2028-09-27	No	4	M	Direct

Footnotes

The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.64 to $35.41, inclusive.
Represents the weighted average sale price of the shares sold ranging from $34.50 to $35.49 per share, inclusive.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.50 to $36.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4).
25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.